Work plan for the CVMP Novel Therapies & Technologies Working Party (NTWP) 2026
Submitted by Anonymous (not verified) on 12 December 2025 - 8:36
Work plan for the CVMP Novel Therapies & Technologies Working Party (NTWP) 2026
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2026
Submitted by Anonymous (not verified) on 12 December 2025 - 8:34
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2026
Work plan for the European Sales and Use of Antimicrobials in veterinary medicine Working Group (ESUAvet WG) 2026
Submitted by Anonymous (not verified) on 12 December 2025 - 8:32
Work plan for the European Sales and Use of Antimicrobials in veterinary medicine Working Group (ESUAvet WG) 2026
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Safety Working Party (SWP-V) 2025
Submitted by Anonymous (not verified) on 12 December 2025 - 8:30
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Safety Working Party (SWP-V) 2025
Checklist for the submission of Day 215 product information annexes for a post-opinion linguistic review (Word file)
Submitted by Anonymous (not verified) on 12 December 2025 - 8:30
Checklist for the submission of Day 215 product information annexes for a post-opinion linguistic review (Word file)
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Immunologicals Working Party (IWP) 2026
Submitted by Anonymous (not verified) on 12 December 2025 - 8:27
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Immunologicals Working Party (IWP) 2026
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Scientific Advice Working Party (SAWP-V) for 2026
Submitted by Anonymous (not verified) on 12 December 2025 - 8:24
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Scientific Advice Working Party (SAWP-V) for 2026
Stability testing for applications for variations to marketing authorisation - Scientific guideline
Submitted by Anonymous (not verified) on 12 December 2025 - 8:20
Stability testing for applications for variations to marketing authorisation - Scientific guideline
Guideline on stability testing for applications for variations to a marketing authorisation - Revision 3
Submitted by Anonymous (not verified) on 12 December 2025 - 8:17
Guideline on stability testing for applications for variations to a marketing authorisation - Revision 3
Human medicines European public assessment report (EPAR): Afstyla, lonoctocog alfa, Date of authorisation: 04/01/2017, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 11 December 2025 - 15:45
Human medicines European public assessment report (EPAR): Afstyla, lonoctocog alfa, Date of authorisation: 04/01/2017, Revision: 12, Status: Authorised